{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:34:11Z","timestamp":1715906051908},"reference-count":14,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14404","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T08:13:02Z","timestamp":1713427982000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment with nivolumab in a patient with gastric cancer with severe liver failure resulting from multiple liver metastases: A case report"],"prefix":"10.3892","volume":"27","author":[{"given":"Fumiyoshi","family":"Ikejiri","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Shimane University Hospital Innovative Cancer Center, Izumo, Shimane 693\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Yokomizo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Shimane University Hospital Innovative Cancer Center, Izumo, Shimane 693\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Shimane University Hospital Innovative Cancer Center, Izumo, Shimane 693\u20118501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"key20240516111846_b1-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20240516111846_b2-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","article-title":"Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data","volume":"24","author":"Wagner","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20240516111846_b3-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"19595","DOI":"10.1002\/cam4.6583","article-title":"Subsite-specific metastatic organotropism and risk in gastric cancer: A population-based cohort study of the US SEER database and a Chinese single-institutional registry","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med"},{"key":"key20240516111846_b4-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","article-title":"S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial","volume":"9","author":"Koizumi","year":"2008","journal-title":"Lancet Oncol"},{"key":"key20240516111846_b5-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"key20240516111846_b6-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40425-016-0166-5","article-title":"Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction","volume":"4","author":"Kanz","year":"2016","journal-title":"J Immunother Cancer"},{"key":"key20240516111846_b7-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40425-017-0252-3","article-title":"Nivolumab as salvage treatment in a patient with HIV-related relapsed\/refractory Hodgkin lymphoma and liver failure with encephalopathy","volume":"5","author":"Sandoval-Sus","year":"2017","journal-title":"J Immunother Cancer"},{"key":"key20240516111846_b8-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/1759-7714.13793","article-title":"To treat or not to treat: A rare case of response to pembrolizumab-based immunotherapy-chemotherapy in non-small cell lung cancer with acute liver failure due to multiple bile duct metastases","volume":"12","author":"Shaforostova","year":"2021","journal-title":"Thorac Cancer"},{"key":"key20240516111846_b9-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"key20240516111846_b10-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/1758834016637585","article-title":"Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature","volume":"8","author":"Quidde","year":"2016","journal-title":"Ther Adv Med Oncol"},{"key":"key20240516111846_b11-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jjco\/hyp161","article-title":"Case series of cetuximab monotherapy for patients with pre-treated colorectal cancer complicated with hyperbilirubinemia due to severe liver metastasis","volume":"40","author":"Shitara","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"key20240516111846_b12-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3904\/kjim.2006.21.4.252","article-title":"Capecitabine and oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction","volume":"21","author":"Hwang","year":"2006","journal-title":"Korean J Intern Med"},{"key":"key20240516111846_b13-ol-27-6-14404","first-page":"4892","article-title":"Effects of hepatic or renal impairment on the pharmacokinetics of immune checkpoint inhibitors","volume":"12","author":"Zhao","year":"2022","journal-title":"Am J Cancer Res"},{"key":"key20240516111846_b14-ol-27-6-14404","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T08:18:55Z","timestamp":1715847535000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,18]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14404","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"article-number":"271"}}